Descripción

Supplementary figure (Figure 193) from a comprehensive Mendelian randomization study with over 200 analyses examining omega-3 polyunsaturated fatty acid effects on inflammatory bowel disease via circulating metabolite mediators.

Figure 193

Chart

Source Paper

Evaluating the Effects of Omega-3 Polyunsaturated Fatty Acids on Inflammatory Bowel Disease via Circulating Metabolites: A Mediation Mendelian Randomization Study.

Metabolites (2023)

PMID: 37887366

DOI: 10.3390/metabo13101041

Cite This Figure

![Figure 193: Supplementary figure (Figure 193) from a comprehensive Mendelian randomization study with over 200 analyses examining omega-3 polyunsaturated fatty acid effects on inflammatory bowel disease via circulating metabolite mediators.]()

> Source: Xiaojing Jia et al. "Evaluating the Effects of Omega-3 Polyunsaturated Fatty Acids on Inflammatory Bo." *Metabolites*, 2023. PMID: [37887366](https://pubmed.ncbi.nlm.nih.gov/37887366/)

<figure>
  <img src="" alt="Supplementary figure (Figure 193) from a comprehensive Mendelian randomization study with over 200 analyses examining omega-3 polyunsaturated fatty acid effects on inflammatory bowel disease via circulating metabolite mediators." />
  <figcaption>Figure 193. Supplementary figure (Figure 193) from a comprehensive Mendelian randomization study with over 200 analyses examining omega-3 polyunsaturated fatty acid effects on inflammatory bowel disease via circulating metabolite mediators.<br>  Source: Xiaojing Jia et al. "Evaluating the Effects of Omega-3 Polyunsaturated Fatty Acids on Inflammatory Bo." <em>Metabolites</em>, 2023. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37887366/">37887366</a></figcaption>
</figure>

Evidencia relacionada

Omega-3 Fatty Acids (EPA/DHA) para Ulcerative Colitis (UC)

Calificación C · 8 estudios

Omega-3 Fatty Acids (EPA/DHA) para Crohn's Disease

Calificación C · 6 estudios